Literature DB >> 17122402

Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K.

Matija Rijavec1, Maruska Budic, Peter Mrak, Manica Müller-Premru, Zdravko Podlesek, Darja Zgur-Bertok.   

Abstract

Colicin K exhibited pronounced inhibitory activity against uropathogenic Escherichia coli (UPEC) strains. Low prevalence of colicin K production and a relatively high prevalence of ColE1-like plasmids were determined among 215 UPEC strains from Slovenia. Sequencing of the colicin K-encoding pColK-K235 revealed a mosaic structure and the presence of the insertion sequence IS2.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17122402      PMCID： PMC1800769          DOI： 10.1128/AEM.01780-06

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  35 in total

1.  Transcription regulation of the colicin K cka gene reveals induction of colicin synthesis by differential responses to environmental signals.

Authors:  I Kuhar; D Zgur-Bertok
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

Review 2.  Mechanisms of colicin binding and transport through outer membrane porins.

Authors:  Zhenghua Cao; Phillip E Klebba
Journal:  Biochimie       Date:  2002 May-Jun       Impact factor: 4.079

3.  Transcriptional profiling of colicin-induced cell death of Escherichia coli MG1655 identifies potential mechanisms by which bacteriocins promote bacterial diversity.

Authors:  Daniel Walker; Matthew Rolfe; Arthur Thompson; Geoffrey R Moore; Richard James; Jay C D Hinton; Colin Kleanthous
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

4.  High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups.

Authors:  Matija Rijavec; Marjanca Starcic Erjavec; Jerneja Ambrozic Avgustin; Rolf Reissbrodt; Angelika Fruth; Veronika Krizan-Hergouth; Darja Zgur-Bertok
Journal:  Curr Microbiol       Date:  2006-06-26       Impact factor: 2.188

5.  Sensitivity of Shiga toxin-producing Escherichia coli (STEC) strains for colicins under different experimental conditions.

Authors:  B J Jordi; K Boutaga; C M van Heeswijk; F van Knapen; L J Lipman
Journal:  FEMS Microbiol Lett       Date:  2001-11-13       Impact factor: 2.742

6.  Genetic organization of plasmid ColJs, encoding colicin Js activity, immunity, and release genes.

Authors:  D Smajs; G M Weinstock
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

7.  Codon-usage based regulation of colicin K synthesis by the stress alarmone ppGpp.

Authors:  I Kuhar; J P van Putten; D Zgur-Bertok; W Gaastra; B J Jordi
Journal:  Mol Microbiol       Date:  2001-07       Impact factor: 3.501

8.  Selection of recently isolated colicinogenic Escherichia coli strains inhibitory to Escherichia coli O157:H7.

Authors:  Gerry P Schamberger; Francisco Diez-Gonzalez
Journal:  J Food Prot       Date:  2002-09       Impact factor: 2.077

9.  Distribution of the usp gene in uropathogenic Escherichia coli isolated from companion animals and correlation with serotypes and size-variations of the pathogenicity island.

Authors:  Hisao Kurazono; Masayuki Nakano; Shingo Yamamoto; Osamu Ogawa; Kazuyo Yuri; Katsuhisa Nakata; Miyuki Kimura; Sou-Ichi Makino; G Balakrish Nair
Journal:  Microbiol Immunol       Date:  2003       Impact factor: 1.955

10.  Expression of proteins using the third domain of the Escherichia coli periplasmic-protein TolA as a fusion partner.

Authors:  Gregor Anderluh; Isa Gökçe; Jeremy H Lakey
Journal:  Protein Expr Purif       Date:  2003-03       Impact factor: 1.650
View more
  8 in total

1.  Interaction of the colicin K bactericidal toxin with components of its import machinery in the periplasm of Escherichia coli.

Authors:  Aurélie Barnéoud-Arnoulet; Marthe Gavioli; Roland Lloubès; Eric Cascales
Journal:  J Bacteriol       Date:  2010-09-24       Impact factor: 3.490

2.  Accumulation of single-stranded DNA in Escherichia coli carrying the colicin plasmid pColE3-CA38.

Authors:  Magali Morales; Hedieh Attai; Kimberly Troy; David Bermudes
Journal:  Plasmid       Date:  2014-11-05       Impact factor: 3.466

3.  Bacteriocin synthesis in uropathogenic and commensal Escherichia coli: colicin E1 is a potential virulence factor.

Authors:  David Smajs; Lenka Micenková; Jan Smarda; Martin Vrba; Alena Sevčíková; Zuzana Vališová; Vladana Woznicová
Journal:  BMC Microbiol       Date:  2010-11-15       Impact factor: 3.605

4.  Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.

Authors:  Maruška Budič; Matija Rijavec; Ziva Petkovšek; Darja Zgur-Bertok
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

5.  Diversity and distribution of nuclease bacteriocins in bacterial genomes revealed using Hidden Markov Models.

Authors:  Connor Sharp; James Bray; Nicholas G Housden; Martin C J Maiden; Colin Kleanthous
Journal:  PLoS Comput Biol       Date:  2017-07-17       Impact factor: 4.475

6.  Enhanced Biofilm Formation and Membrane Vesicle Release by Escherichia coli Expressing a Commonly Occurring Plasmid Gene, kil.

Authors:  Ryoma Nakao; Si Lhyam Myint; Sun Nyunt Wai; Bernt Eric Uhlin
Journal:  Front Microbiol       Date:  2018-11-07       Impact factor: 5.640

7.  O-Antigen-Dependent Colicin Insensitivity of Uropathogenic Escherichia coli.

Authors:  Connor Sharp; Christine Boinett; Amy Cain; Nicholas G Housden; Sandip Kumar; Keith Turner; Julian Parkhill; Colin Kleanthous
Journal:  J Bacteriol       Date:  2019-01-28       Impact factor: 3.490

8.  Prevalence of Virulence Genes and Their Association with Antimicrobial Resistance Among Pathogenic E. coli Isolated from Egyptian Patients with Different Clinical Infections.

Authors:  Rehab Mahmoud Abd El-Baky; Reham Ali Ibrahim; Doaa Safwat Mohamed; Eman Farouk Ahmed; Zeinab Shawky Hashem
Journal:  Infect Drug Resist       Date:  2020-04-28       Impact factor: 4.003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.